King Pharmaceuticals KG Increase (Decrease) in Funds Held under Reinsurance Agreements
Increase (Decrease) in Funds Held under Reinsurance Agreements at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements.
The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's increase (decrease) in funds held under reinsurance agreements.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is King Pharmaceuticals's increase (decrease) in funds held under reinsurance agreements?
- King Pharmaceuticals (KG) reported increase (decrease) in funds held under reinsurance agreements of -$3.02M in Q1 2026.
- What does increase (decrease) in funds held under reinsurance agreements mean?
- The net change in funds retained by the company under reinsurance agreements, representing liabilities owed to reinsurers. This balance reflects the contractual structure of reinsurance arrangements and the company's obligation to hold funds on behalf of partners. It is a critical metric for understanding the company's liquidity obligations and reinsurance capital management.